ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company that develops, manufactures, and markets high-quality branded and generic prescription pharmaceutical products. The team focuses on sustainable growth by scaling up their Rare Disease business, enhancing their generics business, and leveraging North American manufacturing capabilities.
.svg)
